Recordati in the world
Recordati’s primary and specialty care operations are present in the Czech Republic and Slovakia, France, Germany, Greece, Ireland, Italy, Poland, Portugal, Romania, Russia and C.I.S., Spain, Switzerland, Turkey, Tunisia and the United Kingdom. Recordati’s operations dedicated to treatments for rare diseases have worldwide coverage: Europe, the Middle East, U.S.A., Canada, Mexico, some South American countries, Malaysia and Japan.  Recordati markets both proprietary products as well as innovative drugs under license from the originating pharmaceutical companies.

Thanks to numerous licensing agreements with international pharmaceutical companies, Recordati's proprietary pharmaceuticals are distributed in more than 100 countries.